Advertisement
Screener

Cumberland Pharmaceuticals Inc. (CPIX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

Cumberland Pharmaceuticals Inc. Cash Flow Breakdown

Cash flow breakdown shows where Cumberland Pharmaceuticals Inc.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $4.93M came in.
  • Fiscal year ended 2025-12-31: from investing, $4.71M went out.
  • Fiscal year ended 2025-12-31: from financing, $6.75M went out.
  • Fiscal year ended 2025-12-31: change in cash, $6.52M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksNew debtNew shares soldOtherNot split outChange in cash
2025-12-31$4.93M-$4.71M-$263.48K$4.72M-$11.20M*-$6.52M
2024-12-31-$612.19K$57.84K-$579.05K*-$357.44K
2023-12-31$6.09M-$105.69K-$740.53K-$6.68M*-$1.44M
2022-12-31$8.45M-$13.67M-$1.05M-$1.01M*-$7.28M
2021-12-31$6.34M-$501.89K-$1.39M-$2.17M*$2.29M
2020-12-31$5.42M-$1.76M-$1.85M$0.00-$5.26M*-$3.46M
2019-12-31$3.06M$2.30M-$3.49M$0.00-$1.59M*$273.68K
2018-12-31$3.11M-$27.72M-$2.88M$200.91K$0.00$9.82M*-$17.47M
2017-12-31-$557.71K$9.51M-$3.72M$0.00$0.00$5.67M*$10.90M
2016-12-31$569.48K-$3.12M-$2.52M*$0.00-$1.03M-$3.69M
2015-12-31$5.88M-$2.34M-$5.34M$21.37K$90.98K-$1.66M
2014-12-31$6.69M-$6.03M-$4.32M$0.00$1.65M$1.00M*-$1.00M
2013-12-31$746.13K-$5.07M-$4.80M-$41.28K$48.02K-$4.36M*-$13.48M
2012-12-31$7.14M-$19.18M-$8.09M$618.02K*$3.76M-$16.25M
2011-12-31$8.72M-$437.77K-$4.25M$629.87K$2.36M*$4.71M
2010-12-31$346.66K-$768.64K-$4.85M$1.36M$3.87M-$12.78M*-$12.81M
2009-12-31$404.97K-$712.34K-$27.30M$18.00M$175.09K$3.97M$72.33M*$66.87M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksNew shares soldOtherNot split outChange in cash
2026-06-30$168.74K*-$1.93M*$0.00*-$5.39M*
2026-03-31$387.02K-$61.17K-$61.00K-$702.30K*-$437.45K
2025-12-31$3.02K*-$3.07M*$0.00*-$681.74K*
2025-09-30$187.18K*-$690.84K*-$10.44K*
2025-06-30$843.80K*$285.86K*-$7.17K*$0.00
2025-03-31$3.90M-$1.23M-$245.87K$4.72M-$10.00M*-$2.86M
2024-12-31$1.90M*-$26.81K*-$98.38K*-$1.28M*
2024-09-30$475.50K*$189.64K*-$98.81K*
2024-06-30-$855.66K*-$46.80K*-$134.25K*
2024-03-31-$2.14M-$58.19K-$247.60K$2.67M*$226.86K
2023-12-31$1.04M*$260.64K*-$188.97K*-$1.30M*
2023-09-30$1.24M*-$95.07K*-$201.65K*-$680.94K*
2023-06-30$5.24M*-$96.81K*-$162.79K*-$3.11M*
2023-03-31-$1.42M-$174.45K-$187.12K-$1.59M*-$3.37M
2022-12-31$3.64M*-$640.77K*-$189.66K*-$2.59M*
2022-09-30$2.64M*$680.80K*-$75.09K*-$1.92M*
2022-06-30$2.33M*-$172.59K*-$208.16K*-$1.00M*
2022-03-31-$150.50K-$13.54M-$580.13K$4.50M*-$9.77M
2021-12-31$1.96M*-$26.80K*-$361.19K*
2021-09-30-$102.01K*-$108.24K*-$247.99K*
2021-06-30$2.70M*-$48.51K*-$474.86K*-$1.43M*
2021-03-31$1.79M-$318.34K-$302.80K-$995.28K*$169.13K
2020-12-31$853.92K*-$316.02K*-$300.06K*-$2.13M*
2020-09-30$857.07K*-$668.75K*-$342.24K*-$573.28K*
2020-06-30$2.82M*-$201.85K*-$766.68K*-$1.50M*
2020-03-31$888.54K-$571.16K-$442.54K-$1.06M*-$1.19M
2019-12-31$857.00K*$1.90M*-$901.14K*-$624.76K*
2019-09-30$734.43K*$6.94M*-$1.37M*$0.00*$6.03M*
2019-06-30$1.85M*-$4.82M*-$507.77K*$0.00*-$3.66M*
2019-03-31-$385.73K-$1.72M-$712.92K$0.00-$507.50K*-$3.33M
2018-12-31$3.72M*-$21.41M*-$496.46K*$7.86M*-$10.32M*
2018-09-30-$1.64M*$4.42M*-$431.77K*$0.00*$2.35M*
2018-06-30$794.09K*$784.64K*-$935.04K*$0.00*$643.68K*
2018-03-31$235.59K-$11.52M-$1.02M$200.91K$1.95M*-$10.15M
2017-12-31-$459.56K*$2.91M*-$830.52K*$0.00*$1.77M*$3.39M*
2017-09-30$992.84K*$6.21M*-$1.10M*$0.00*$0.00*$7.40M*
2017-06-30-$2.53M*$816.98K*-$1.24M*$0.00*$0.00*$2.60M*-$358.14K*
2017-03-31$1.44M-$429.54K-$545.92K$0.00$0.00$463.91K
2016-12-31$819.79K*-$1.50M*-$641.32K*$0.00*-$119.14K*-$1.04M*
2016-09-30$293.62K*-$522.01K*-$190.35K*$0.00*-$72.25K*-$291.00K*
2016-06-30-$1.14M*-$144.35K*-$709.75K*$0.00*-$407.02K*$1.80M*-$603.54K*
2016-03-31$598.49K-$953.48K-$979.29K$0.00-$427.99K-$1.76M
2015-12-31$1.32M*-$338.64K*-$669.09K*$0.00*-$379.60K*-$113.23K*
2015-09-30$485.63K*$46.59K*-$1.31M*$0.00*$156.63K*-$624.39K*
2015-06-30$2.03M*-$879.06K*-$1.64M*$9.37K*$295.40K*-$104.07K*
2015-03-31$2.03M-$1.17M-$1.71M$12.00K$18.56K-$821.29K
2014-12-31$2.74M*-$1.51M*-$1.58M*$0.00*$575.93K*$221.96K*
2014-09-30$2.14M*-$753.30K*-$1.16M*$0.00*$365.75K*$593.24K*
2014-06-30$835.82K*-$1.70M*-$660.64K*$0.00*$523.34K*$2.88K*
2014-03-31$982.57K-$2.07M-$919.58K$0.00$188.01K-$1.82M
2013-12-31-$192.63K*$233.36K*-$882.47K*$16.00*$559.93K*-$4.86M*-$5.14M*
2013-09-30-$853.56K*-$516.66K*-$756.13K*$0.00*-$527.20K*-$1.00M*-$3.65M*
2013-06-30$121.67K*-$1.48M*-$1.22M*$0.00*-$463.41K*-$1.54M*
2013-03-31$1.67M-$3.31M-$1.94M-$41.29K$478.70K-$3.14M
2012-12-31$1.99M*$1.20M*-$1.26M*$37.92K*$1.58M*$3.55M*
2012-09-30$1.90M*-$1.47M*-$3.26M*$34.50K*$1.32M*-$1.47M*
2012-06-30$634.81K*-$2.70M*-$1.22M*$0.00*$663.91K*-$3.37M*
2012-03-31$2.61M-$16.21M-$2.35M$545.60K$191.08K-$14.96M
2011-12-31$1.03M*-$55.53K*-$1.36M*-$51.77K*-$301.91K*-$475.66K*
2011-09-30$2.76M*-$230.06K*-$1.33M*$158.13K*$1.14M*$1.24M*
2011-06-30$3.95M*-$97.63K*-$779.82K*$90.45K*$1.38M*-$666.67K*$3.87M*
2011-03-31$983.98K-$54.55K-$772.02K$433.06K*$141.08K$64.87K
2010-12-31-$686.44K*-$325.29K*-$717.14K*$180.62K*$2.62M*-$694.17K*$375.63K*
2010-09-30$277.94K*-$236.30K*-$1.05M*$202.85K*$794.10K*-$5.97M*-$5.98M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
Aardvark Therapeutics, Inc. (AARD)United States$0.121B-1.80
Coya Therapeutics, Inc. (COYA)United States$0.121B-6.35
OnKure Therapeutics, Inc. (OKUR)United States$0.119B-3.13
INOVIO PHARMACEUTICALS, INC. (INO)United States$0.125B-1.35
IMMUNIC, INC. (IMUX)United States$0.127B-1.88
Immuneering Corp (IMRX)United States$0.113B-12.51
Quantum Cyber N.V. (QUCY)$0.113B
MEDICINOVA INC (MNOV)United States$0.130B-6.04
BICYCLE THERAPEUTICS PLC (BCYC)$0.112B-1.56
NRX Pharmaceuticals, Inc. (NRXP)United States$0.131B-6.31